Neuren Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Nov '25 Nov 26, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	2,484	1,588	3,178	1,001	475	147	Upgrade
Market Cap Growth	24.35%	-50.04%	217.33%	110.87%	222.46%	-40.72%	Upgrade
Enterprise Value	2,185	1,374	3,092	970	457	138	Upgrade
Last Close Price	19.64	12.50	24.97	7.95	3.77	1.28	Upgrade
PE Ratio	17.11	11.18	20.23	5442.54	-	-	Upgrade
Forward PE	69.87	19.45	32.20	19.55	135.13	-	Upgrade
PS Ratio	11.35	7.32	13.70	64.96	148.54	205.40	Upgrade
PB Ratio	7.68	4.36	15.49	24.08	12.10	6.09	Upgrade
P/TBV Ratio	7.68	4.36	15.49	24.08	12.10	6.09	Upgrade
P/FCF Ratio	18.06	-	17.19	279.73	-	-	Upgrade
P/OCF Ratio	18.06	-	17.18	278.25	-	-	Upgrade
EV/Sales Ratio	9.98	6.34	13.33	62.94	142.84	192.61	Upgrade
EV/EBITDA Ratio	11.87	7.67	15.52	-	-	-	Upgrade
EV/EBIT Ratio	11.87	7.67	15.52	-	-	-	Upgrade
EV/FCF Ratio	15.88	-	16.73	271.04	-	-	Upgrade
Asset Turnover	0.78	0.66	1.59	0.37	0.10	0.04	Upgrade
Quick Ratio	40.42	8.69	5.68	24.59	47.58	33.13	Upgrade
Current Ratio	40.42	8.73	5.78	25.77	49.87	33.13	Upgrade
Return on Equity (ROE)	54.96%	49.92%	127.30%	0.46%	-24.57%	-48.32%	Upgrade
Return on Assets (ROA)	41.13%	34.05%	85.52%	-1.10%	-15.83%	-27.98%	Upgrade
Return on Capital (ROIC)	42.42%	39.35%	100.92%	-1.13%	-16.22%	-28.94%	Upgrade
Return on Capital Employed (ROCE)	56.90%	49.20%	97.10%	-1.80%	-21.00%	-36.40%	Upgrade
Earnings Yield	6.00%	8.95%	4.94%	0.02%	-1.64%	-6.24%	Upgrade
FCF Yield	5.54%	-0.71%	5.82%	0.36%	-2.10%	-5.49%	Upgrade
Buyback Yield / Dilution	0.98%	-0.01%	-1.44%	-8.76%	-10.71%	-6.88%	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.